Clinical Trial Search

Primary: Colorectal Cancer Screening Participation, Defined as Completion of a Guaiac or Immunochemical Stool Occult Blood Test, Colonoscopy, Sigmoidoscopy, or Barium Enem…

Primary: Percent of Patients Receiving GI Consult for FOBT+ Results — 39; 47; 64; 51 percent patients receiving GI consult

Primary: Facilitators and Barriers to Implementing Decision Aids, Provider Notifications, and Personal Risk Calculation Using an Electronic Health Record (EHR) to Promote…

Primary: Colorectal Cancer Stage (pTNM) — 46; 85 Participants

Primary: FIT Completion — 10.4; 13.9 Model based percentage of participants — p=.05

Primary: Sensitivity and Specificity of the Exact CRC Screening Test With Comparison to Colonoscopy, Both With Respect to Cancer. — 92.3; 73.8; 93.3; 73.3 percent

Primary: Completion of a Fecal Occult Blood Test (FOBT) — 185; 84 participants

Primary: Assess Colorectal Cancer Screening Completion — 305; 130 Participants

Primary: Colorectal Cancer Screening — 127; 112 participants — p=0.01

Primary: Proportion of Subjects Who Completed Colorectal Cancer (CRC) Screening Within 6 Months (Trial - Age Group 50-75) — 598; 192 Participants

Primary: Participants Completing CRC Screening Per Electronic Medical Record Documentation — 37; 59; 27 Participants

Primary: FIT Completion Among Patients Offered Any Incentive vs. Outreach Alone Each Year — 2391; 738; 1255; 394 Participants — p=0.59

Primary: Number of Participants Who Completed Colorectal Cancer Screening — 110; 95; 113; 113 Participants

Primary: Colorectal Cancer (CRC) Screening Rate. — 40.1; 40.2; 19.3 percentage of participants

Primary: CRC Screening Completion Rates — 550; 751 Participants — p=0.05

Primary: Percentage of Participants Who Undergo Screening Within 6 Months of Outreach — 17; 31 Participants

Primary: Colorectal Cancer (CRC) Screening Completion — 17; 69 participants — p=0.32

Primary: Patient Adherence (Test Completion) — 104; 116; 96 participants — p=0.046

Primary: Overall Screening Adherence — 88; 153; 115; 44 Participants — p=<0.001

Primary: Likelihood of Any Colorectal Cancer (CRC) Screening (for Study-eligible Patients) — 11.8; 4.5 Percentage of participants

Primary: Number of Participants With CRC Screening Ordered — 162; 114 Participants — p=0.491

Primary: Concordance Between Patient Preference and Test Ordered — 148; 147 Participants — p=0.40

Primary: Use of FOBT ColoCARE Home Kit — 14; 2; 14; 0 participants

Primary: Initial CRC Screening — 213; 205 Participants — p=0.61

Primary: Number (and Proportion) of Participants Who Request a Colorectal Cancer (CRC) Screening Test — 16; 17; 22; 19 Participants

Primary: Change in Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening — 1 score on a scale — p=0.0001

Primary: Number of Participants Who Completed Colorectal Cancer Screening — 11; 16; 18; 19 Participants

Primary: Specificity of the Multi-target Stool DNA Test in Average Risk Population, Ages 45-49 — 95.3 percentage of participants

Primary: Number of Participants to Return Fecal Immunochemical Test (FIT) — 3; 4; 9 Participants

Primary: Completion of a Colorectal Cancer Screening — 5; 31 participants